chr1-39485632-T-G
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The NM_001394062.1(MACF1):āc.22506T>Gā(p.Phe7502Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00374 in 1,614,186 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F7502S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001394062.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MACF1 | NM_001394062.1 | c.22506T>G | p.Phe7502Leu | missense_variant | 101/101 | ENST00000564288.6 | NP_001380991.1 | |
MACF1 | NM_012090.5 | c.16131T>G | p.Phe5377Leu | missense_variant | 93/93 | NP_036222.3 | ||
MACF1 | NM_001397473.1 | c.10386T>G | p.Phe3462Leu | missense_variant | 41/41 | NP_001384402.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MACF1 | ENST00000564288.6 | c.22506T>G | p.Phe7502Leu | missense_variant | 101/101 | 5 | NM_001394062.1 | ENSP00000455274 |
Frequencies
GnomAD3 genomes AF: 0.00282 AC: 429AN: 152192Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00225 AC: 566AN: 251426Hom.: 4 AF XY: 0.00247 AC XY: 336AN XY: 135898
GnomAD4 exome AF: 0.00383 AC: 5601AN: 1461876Hom.: 16 Cov.: 30 AF XY: 0.00374 AC XY: 2723AN XY: 727236
GnomAD4 genome AF: 0.00282 AC: 429AN: 152310Hom.: 1 Cov.: 32 AF XY: 0.00262 AC XY: 195AN XY: 74470
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | MACF1: BS2 - |
Abnormal corpus callosum morphology Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | Sep 01, 2017 | this variant was indentified in an individual with malformations of cortical development - |
MACF1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 11, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at